Skip to main content
Normal View

Medicinal Products

Dáil Éireann Debate, Tuesday - 30 May 2023

Tuesday, 30 May 2023

Questions (664)

Jennifer Murnane O'Connor

Question:

664. Deputy Jennifer Murnane O'Connor asked the Minister for Health the considerations his Department is giving to the inclusion of the drugs saxenda and ozempic, both now recognised as valuable medications in the treatment of obesity, to the drugs payment scheme for non-diabetic patients; if there are plans to widen the prescription of saxenda and ozempic to medical card holders with a BMI of greater than 35 as a preventative medicine; and if he will make a statement on the matter. [25689/23]

View answer

Written answers

The Health Service Executive (HSE) has statutory responsibility for pricing and reimbursement decisions under the community drug schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. Therefore, this matter has been referred to the HSE for attention and direct reply to the Deputy.

Top
Share